These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 194349)

  • 1. [Elastolytic activity and free oxyproline in the blood in different types of hyperlipoprotenemia in patients with ischemic heart disease].
    Mikunis RI; Serkova VK
    Ter Arkh; 1977; 49(4):37-40. PubMed ID: 194349
    [No Abstract]   [Full Text] [Related]  

  • 2. [Plasma glycosaminoglycans in patients with coronary disease and hyperlipidemia].
    Giannini SD; Strunz CM; Forti N; Credidio Rde A; Diament J; Dereviacki BE; de Góis JM; de Serro-Azul LG
    Arq Bras Cardiol; 1986 May; 46(5):307-10. PubMed ID: 3471185
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of heparin and clofibrate on blood-serum lipid levels in patients with ischaemic heart disease.
    Haviar V; Riecanský L; Kusá O; Luknárová O
    Cor Vasa; 1972; 14(3):188-96. PubMed ID: 4344417
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hydroxyproline content in blood and urine in ischemic heart disease].
    Nikitin IuP; Korobkova EN
    Kardiologiia; 1977 Aug; 17(8):84-9. PubMed ID: 200786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of hyperlipidemia in coronary artery disease.
    Kossmann CE
    J Tenn Med Assoc; 1982 Aug; 75(8):543-7. PubMed ID: 7132342
    [No Abstract]   [Full Text] [Related]  

  • 6. [Disruption of the cholesterol-transport function of lipoproteins in the blood plasma of patients with ischemic heart disease].
    Gerasimova EN; Perova NV; Kurdanov KhA; Polesskiĭ VA
    Vopr Med Khim; 1984; 30(6):71-6. PubMed ID: 6528538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma lipoproteins and coronary heart disease.
    Scanu AM
    Ann Clin Lab Sci; 1978; 8(2):79-83. PubMed ID: 205164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations of surface charges of plasma lipoproteins in ischemic heart disease.
    Panasenko OM; Azizova OA; Arnold K; Borin ML
    Biomed Biochim Acta; 1987; 46(1):97-102. PubMed ID: 3034240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma lipoprotein cholesterol and coronary heart disease.
    Misra KP; Suresh S; Balachandran G; Reddy KN; Rao PM; Radhakrishnan T; Shanmugasundaram KR
    J Assoc Physicians India; 1980 Nov; 28(11):399-404. PubMed ID: 7216970
    [No Abstract]   [Full Text] [Related]  

  • 10. Medical Grand Rounds. Hyperlipidemia and low HDL Cholesterol.
    J Tenn Med Assoc; 1980 Sep; 73(9):641-6. PubMed ID: 7442237
    [No Abstract]   [Full Text] [Related]  

  • 11. [Malondialdehyde content of plasma lipoproteins and thrombocytes in patients with ischemic heart disease].
    Zykova VP; Gasilin VS; Kurdanov KhA; Bazanov EA
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1984; 7(2):82-6. PubMed ID: 6508934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholesterol of alpha and beta lipoproteins in ischemic heart disease.
    Alvarado M; Méndez D; Rivera-Hidalgo PR
    Arch Invest Med (Mex); 1981; 12(4):589-98. PubMed ID: 7332395
    [No Abstract]   [Full Text] [Related]  

  • 13. [Characteristics of the structural organization of lipoproteins in the blood plasma of patients with ischemic heart disease using the spin probe method].
    Panasenko OM; Azizova OA; Torkhovskaia TI; Dudaev VA
    Vopr Med Khim; 1984; 30(6):40-5. PubMed ID: 6098993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hyperlipidemia in patients with coronary disease (author's transl)].
    Proniewska W; Diakowski J; Kaliciński A; Modrzejewski W
    Przegl Lek; 1978; 35(4-5):456-7. PubMed ID: 211558
    [No Abstract]   [Full Text] [Related]  

  • 15. [Prevention of coronary disease: role of high density lipoproteins (HDL)].
    Pouliot M
    Union Med Can; 1983 Jan; 112(1):28-30. PubMed ID: 6836774
    [No Abstract]   [Full Text] [Related]  

  • 16. [Free hydroxyproline content of the blood serum in patients with coronary arteriosclerosis].
    Vorob'eva LP; Bazanov EA; Suchkova SN
    Kardiologiia; 1976 Feb; 16(2):41-5. PubMed ID: 966441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should hyperlipidemia be treated? Available agents and clinical results.
    Gotto AM
    Cardiovasc Res Cent Bull; 1978; 17(1):3-27. PubMed ID: 223761
    [No Abstract]   [Full Text] [Related]  

  • 18. [Lipoproteins and coronary cardiopathy].
    Angelino PF; Abrate M; Pizzuti A; Bernardi FR; Bulgarelli GC; Aillon C; Passarino G; Carta Q; Della Beffa V
    Minerva Cardioangiol; 1981 Apr; 29(4):163-7. PubMed ID: 7242947
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum HDL-cholesterol, apo-A-I and apo-E levels in patients with abnormal coronary arteries.
    Tan MH; Weldon KL; Albers JJ; Cheung MC; Havel RJ; Vigne JL
    Clin Invest Med; 1980; 3(3-4):225-32. PubMed ID: 6784991
    [No Abstract]   [Full Text] [Related]  

  • 20. Cerivastatin modulates antiatherogenic properties of high-density lipoproteins in patients with coronary heart disease and hyperlipidemia.
    Ozerova IN; Jeevan DM; Serdyuk AP; Paramonova IV; Akhmedzhanov NM; Metel'skaya VA; Perova NV
    Bull Exp Biol Med; 2000 Oct; 130(10):983-5. PubMed ID: 11177300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.